Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma
Open accessAbstract
Diffuse Intrinsic Pontine Gliomas (DIPGs) are deadly paediatric brain tumours where needle biopsies help guide diagnosis and targeted therapies. To address spatial heterogeneity, here we analyse 134 specimens from various neuroanatomical structures of whole autopsy brains from nine DIPG patients. Evolutionary reconstruction indicates histone 3 (H3) K27M--including H3.2K27M--mutations potentially arise first and are invariably associated with specific, high-fidelity obligate partners throughout the tumour and its spread, from diagnosis to end-stage disease, suggesting mutual need for tumorigenesis. These H3K27M ubiquitously-associated mutations involve alterations in TP53 cell-cycle (TP53/PPM1D) or specific growth factor pathways (ACVR1/PIK3R1). Later oncogenic alterations arise in sub-clones and often affect the PI3K pathway. Our findings are consistent with early tumour spread outside the brainstem including the cerebrum. The spatial and temporal homogeneity of main driver mutations in DIPG implies they will be captured by limited biopsies and emphasizes the need to develop therapies specifically targeting obligate oncohistone partnerships.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Alterations affecting the p53 pathway occur in about 87% of H3.3K27M tumors.
“These include alterations affecting the p53 pathway in ~87% of H3.3K27M tumors”
From H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas (2017) · cites this paper as Nikbakht et al., 2016
Loss-of-function mutations in ATRX occur with increasing frequency in older patients.
“loss-of-function mutations in ATRX, which occur with increasing frequency in older patients”
From H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas (2017) · cites this paper as Nikbakht et al., 2016
In H3.3K27M DIPG, ATRX loss is rare, less than 10%, and subclonal.
“This is in contrast to H3.3K27M DIPG where ATRX loss is rare (less than 10%) and subclonal (Nikbakht et al., 2016), potentially in accordance with our model.”
From H3.3K27M Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade Gliomas (2017) · cites this paper as Nikbakht et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 39 · Cited by 252
- Authors
- Nikbakht, H., Panditharatna, E., Mikael, L. G., Li, R., Gayden, T., Osmond, M., Ho, C.-Y., Kambhampati, M., Hwang, E. I., Faury, D., Siu, A., Papillon-Cavanagh, S., Bechet, D., Ligon, K. L., Ellezam, B., Ingram, W. J., Stinson, C., Moore, A. S., Warren, K. E., Karamchandani, J., Packer, R. J., Jabado, N., Majewski, J., & Nazarian, J.
- Affiliations
- McGill University and Génome Québec Innovation Centre (CA)
- Children's National (US)
- Research Institute of the McGill University Health Centre (CA)
- McGill University (CA)
- George Washington University (US)
- Dana-Farber Cancer Institute (US)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- The University of Queensland (AU)
- National Institutes of Health (US)
- Montreal Neurological Institute and Hospital (CA)
- Corresponding author
- Jabado, Nada
- Majewski, Jacek
- Nazarian, Javad
- ORCID
- Venue
- Nature Communications
- Published
- 2016-04-06
- Volume
- 7
- Issue
- 1
- Pages
- 11185-11185
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4823825
- OpenAlex
- W2321002580
- Cited by
- 252
- References
- 39
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 14 · 2023: 22 · 2022: 25 · 2021: 39 · 2020: 27 · 2019: 35 · 2018: 27 · 2017: 31 · 2016: 4 · 2014: 1
- FWCI
- 19.77
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Musella Foundation For Brain Tumor Research and Information
- George Washington University (UL1TR000075)
- McGill University
- Genome Canada
- Children's Hospital Foundation
- Fondation de l'Hôpital de Montréal pour enfants
- National Institutes of Health (UL1TR000075, KL2TR000076)
- Canadian Institutes of Health Research (KL2TR000076, UL1TR000075)
- National Cancer Institute (P01CA196539)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- diffuse intrinsic pontine glioma, H3K27M mutation, histone H3, tumor heterogeneity, driver mutations, clonal evolution, TP53, PPM1D, ACVR1, PIK3R1, PI3K signaling, metastasis, pediatric brain tumors, biopsy limitations
- MeSH terms
- Protein Phosphatase 2C, Autopsy, Brain Mapping, Brain Stem, Child, Glioma, Histones, Humans, Mutation, Phosphoprotein Phosphatases, Stereotaxic Techniques, Time Factors, Signal Transduction, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Phosphatidylinositol 3-Kinases, Brain Stem Neoplasms, Activin Receptors, Type I, Cerebrum, Class Ia Phosphatidylinositol 3-Kinase, Clonal Evolution, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review